• 1. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 2. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 3. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 4. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 5. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles 4,5-disubstituted thiazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazoles 4,5-disubstituted thiazoles
• Catalysts and Inorganic Chemicals Catalysts

Introduction to 3-Ethyl-5-(2-hydroxyethyl)-4-methylthiazolium bromide (CAS No. 54016-70-5)

3-Ethyl-5-(2-hydroxyethyl)-4-methylthiazolium bromide, identified by the chemical formula CAS No. 54016-70-5, is a compound that has garnered significant attention in the field of medicinal chemistry and materials science due to its unique structural properties and potential applications. This zwitterionic compound belongs to the thiazolium family, which is well-known for its versatility in various biochemical and pharmaceutical contexts. The presence of both ethyl and hydroxyethyl substituents on the thiazole ring introduces specific functional groups that enhance its reactivity and utility in synthetic chemistry.

The compound's structure consists of a central thiazole ring substituted with a methyl group at the 4-position, an ethyl group at the 3-position, and a 2-hydroxyethyl group at the 5-position. The bromide counterion further influences its solubility and interaction with biological systems. This particular arrangement of functional groups makes 3-Ethyl-5-(2-hydroxyethyl)-4-methylthiazolium bromide a promising candidate for applications in drug delivery systems, antimicrobial agents, and as a building block for more complex molecular architectures.

In recent years, there has been growing interest in zwitterionic compounds due to their ability to form stable interactions with biological molecules. The zwitterionic nature of 3-Ethyl-5-(2-hydroxyethyl)-4-methylthiazolium bromide contributes to its biocompatibility and low toxicity, making it suitable for use in biomedical applications. Researchers have explored its potential as a component in non-viral gene delivery systems, where its ability to form stable complexes with nucleic acids could enhance the efficiency of gene transfer.

Moreover, the hydroxyl group in the 2-hydroxyethyl side chain provides a site for further chemical modification, allowing for the development of derivatives with tailored properties. This flexibility has led to investigations into its use as a precursor for synthesizing novel antimicrobial agents. Studies have shown that thiazolium derivatives exhibit broad-spectrum antimicrobial activity by disrupting bacterial cell membranes. The ethyl and hydroxyethyl groups may contribute to improved solubility and membrane permeability, enhancing the compound's efficacy against resistant strains.

The pharmaceutical industry has also been exploring 3-Ethyl-5-(2-hydroxyethyl)-4-methylthiazolium bromide as a potential candidate for anti-inflammatory and anti-cancer therapies. Its structural motifs are reminiscent of known bioactive molecules, suggesting that it may interact with specific targets within cellular pathways. Preliminary computational studies have indicated that this compound could interfere with key enzymes involved in inflammation and cancer progression. While further experimental validation is needed, these findings highlight its potential as a lead compound for drug discovery.

From a materials science perspective, 3-Ethyl-5-(2-hydroxyethyl)-4-methylthiazolium bromide has been investigated for its role in self-assembling systems. Zwitterionic compounds are known to form micelles and vesicles under certain conditions, which can be utilized for encapsulating drugs or other bioactive molecules. The ability to control the size and stability of these structures makes them attractive for targeted drug delivery applications. Additionally, the compound's compatibility with water-based environments enhances its suitability for biomedical uses.

The synthesis of 3-Ethyl-5-(2-hydroxyethyl)-4-methylthiazolium bromide involves multi-step organic reactions that require careful optimization to ensure high yield and purity. The introduction of the ethyl and hydroxyethyl groups necessitates precise control over reaction conditions to avoid unwanted side products. Advances in synthetic methodologies have enabled more efficient production processes, making it feasible to scale up synthesis for industrial applications.

In conclusion, 3-Ethyl-5-(2-hydroxyethyl)-4-methylthiazolium bromide (CAS No. 54016-70-5) is a multifaceted compound with significant potential in pharmaceuticals, materials science, and biotechnology. Its unique structural features make it suitable for diverse applications, from drug delivery to antimicrobial agents and advanced materials. As research continues to uncover new possibilities, this compound is poised to play an increasingly important role in addressing challenges across multiple scientific disciplines.

• 754184-34-4(Thiazolium, 3,3'-(1,12-dodecanediyl)bis[5-ethyl-4-methyl-)
• 46719-49-7(Thiazolium,5-(2-hydroxyethyl)-4-methyl-3-(phenylmethyl)-)
• 121028-75-9(Thiazolium,3-ethyl-4,5-dimethyl-, bromide (1:1))
• 7598-25-6(2-[4-methyl-3-(2-phenylethyl)-1,3-thiazol-3-ium-5-yl]ethanol;iodide)
• 4568-71-2(2-(3-benzyl-4-methyl-thiazol-3-ium-5-yl)ethanol;chloride)
• 16311-69-6(5-(2-Hydroxyethyl)-3,4-dimethylthiazolium iodide)
• 21975-24-6(Thiazolium, 5-(2-hydroxyethyl)-3,4-dimethyl-, chloride)
• 639459-71-5(Thiazolium, 3,3'-(1,12-dodecanediyl)bis[5-ethyl-4-methyl-, diiodide)
• 60543-21-7(Thiazolium, 5-ethyl-3,4-dimethyl-, iodide)
• 321915-72-4(1,12-Bis4-methyl-5-(2-hydroxyethyl)thiazol-3-ium-3-yldodecanedibromide)